Trump administration cancels multi-million dollar bird flu vaccine contract with Moderna
The pharmaceutical giant was awarded the multi-million dollar contract by the Biden administration last year, as the H5N1 virus began to ravage US dairy and poultry farms.
It has since infected more than 70 people in America, killing one, and experts say it is only a matter of time before it starts to spread between humans – an event that could trigger a new pandemic.
Just yesterday, an 11 year old boy died in Cambodia after becoming infected, the fifth H5N1 death in the region this year.
A spokesperson for the US Department of Health and Human Services (HHS) said that after an internal review, the agency had decided to cancel the Moderna contact.
Health secretary Robert F. Kennedy Jr, a long time vaccine sceptic, has repeatedly expressed concern over the safety of mRNA vaccines despite them having saved millions of lives during the Covid-19 pandemic.
This week Mr Kennedy also announced that mRNA Covid vaccines would no longer be recommended for healthy children or healthy pregnant women.
Currently, the US lacks sufficient bird flu vaccine stockpiles, with only 0.82 doses available per person, according to disease analytics firm Airfinity.
The agreement with Moderna was intended to strengthen the country's pandemic preparedness by diversifying its emergency H5N1 vaccine stocks.
It is thought mRNA vaccines can be developed and produced more rapidly than traditional flu vaccines which are grown in chicken eggs – a method that is both slow and difficult to scale.
The cancellation of the contract came on the same day Moderna announced positive results for the jab from its first preliminarily clinical trials: testing of 300 people found the H5N1 vaccines to be 98 per cent efficacy, and 'generally well tolerated.'
'The cancellation [of the contract] means that the government is discarding what could be one of the most effective and rapid tools to combat an avian influenza outbreak,' Amesh Adalja, senior scholar at the Johns Hopkins Center for Health Security told Reuters.
The European Union has secured 450 million doses of bird flu vaccines – enough for one dose per EU resident – from multiple manufacturers, including CSL Seqirus, GSK, and Pfizer.
Moderna, founded just 11 years ago and based in Massachusetts, received over $30 billion in US government funding during the Covid-19 pandemic under the leadership Dr Anthony Fauci, which allowed it to quickly develop and deploy millions of doses of its vaccines.
Protect yourself and your family by learning more about Global Health Security
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
16 minutes ago
- The Hill
China hawks skeptical of Trump chip deal
Trump on Monday agreed to allow tech giants Nvidia and AMD to secure export licenses to sell their advanced artificial intelligence (AI) chips in China in exchange for a 15 percent cut of the profits. The White House said Tuesday that more such deals could be on the table. The unusual deal doesn't just raise legal questions. Experts say the U.S. should be wary of turning over American-made technology that could boost its adversary's AI capabilities, at a time when the two countries are fiercely competing for dominance. The security concerns appear to be a two-way street. China urged tech companies there to avoid any purchase of Nvidia's H20 chip, citing security issues. The move once again has Trump at odds with Congress's China hawks, who argue the administration is shortchanging America's national security interests to make a buck. Rep. Raja Krishnamoorthi (Ill.), the top Democrat on the House Select Committee on the Chinese Communist Party, in a statement said the most troubling part of the deal was a contradiction at the heart of the policy. 'The administration cannot simultaneously treat semiconductor exports as both a national security threat and a revenue opportunity,' he said. 'By putting a price on our security concerns, we signal to China and our allies that American national security principles are negotiable for the right fee.' The same panel's GOP chair, Rep. John Moolenaar (Mich.), said there are 'questions about the legal basis' for such a deal. 'Export controls are a frontline defense in protecting our national security, and we should not set a precedent that incentivizes the Government to grant licenses to sell China technology that will enhance its AI capabilities,' he said in a statement.
Axios
16 minutes ago
- Axios
D.C. business leaders warn Trump's crackdown may hurt tourism
Restaurant and hospitality groups are pushing back on President Trump 's depiction of the District as a hotbed of "crime, bloodshed, bedlam and squalor," saying the city is safe — and open for business. Why it matters: Several D.C. industry leaders say Trump's rhetoric could deter visitors and hurt a tourism economy already affected by the administration's policies and mass federal firings. By the numbers: 48 groups have canceled or changed their D.C. plans since October due to political concerns, Destination D.C. tells Axios. Their estimated economic loss for the city: more than $61 million, based on projected hotel room nights. State of play: The tourism marketing organization is planning outreach to groups that have booked events or are considering them, according to the Washington Business Journal. That includes sharing stats that show D.C. violent crime has hit a 30-year low. The organization is also joining in on the viral " love letter" to D.C. trend, where locals share real-life portrayals of the city. Reality check: Destination D.C. tells Axios that the estimated 2025 losses due to political reasons represent just 2% of the projected revenue generated for the city, "so there is still a lot of positive production happening for the city." Meanwhile, the Restaurant Association Metropolitan Washington (RAMW) has a message ahead of Summer Restaurant Week, which starts Monday: "D.C. is open for business." "Next week is crucial for some to make it through Labor Day," RAMW CEO Shawn Townsend says of the weeklong event, which aims to draw diners to offset a typical August slowdown. "Folks may be thinking, 'Why go Downtown when I can do Restaurant Week in Bethesda or Tysons?'" Zoom in: RAMW is telling its members to promote positivity on social media and talk directly to diners if they cancel reservations: "It's like any major city — be careful — but D.C. is not a war zone." It's not just fear of crime — the armed presence may hurt, too. "If I'm coming in from out of town, I wouldn't want to bring my family to a city that has National Guard on every corner," says Townsend.
The Hill
16 minutes ago
- The Hill
NIH cancels mRNA vaccine contracts, citing lack of public trust
National Institutes of Health Director Jay Bhattacharya claims the federal government recently cancelled millions of dollars' worth of mRNA research contracts because the general public does not trust the technology. Bhattacharya explained the reason behind the abrupt contract cancellations, first, during an episode of Republican political strategist Steve Bannon's podcast 'War Room' last week and again in an opinion piece recently published in The Washington Post. In the article, Bhattacharya called the mRNA platform a 'promising technology' and acknowledged that it may lead to breakthroughs in treatment for diseases like cancer. 'But as a vaccine intended for broad public use, especially during a public health emergency, the platform has failed a crucial test: earning public trust,' he wrote. 'No matter how elegant the science, a platform that lacks credibility among the people it seeks to protect cannot fulfill its public health mission.' Bhattacharya's explanation for the administration's pivot away from mRNA technology differs from that of his boss, Health and Human Services Secretary Robert F. Kennedy Jr. Kennedy announced last week the agency would wind down its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA) and cancel $500 million worth of contracts related to the technology. He said that mRNA technologies funded during the pandemic failed to meet current scientific standards and that the federal government would shift its focus to whole-virus vaccines and novel platforms. Bhattacharya expressed concern in the article about mRNA vaccines' ability to direct human cells to produce spike proteins to trigger an immune response. He argues the scientific community does not have a clear understanding of where mRNA product stays in the body, for how long, and whether other proteins are created in the process. Scott Hensley, a microbiology professor at the University of Pennsylvania's Perelman School of Medicine, told STAT that these are also issues with vaccines that use live but weakened viruses like the measles, mumps, and rubella vaccine, which federal health agencies have deemed safe and effective. 'This is why we complete human clinical studies before vaccines are widely used in humans,' he told the outlet. 'The mRNA and live attenuated vaccine platforms have both proven to be safe and effective in clinical trials.' He blamed public distrust in mRNA on the Biden administration's COVID-19 vaccine mandates during the pandemic. Bhattacharya expressed concern in the article about mRNA vaccines' ability to direct human cells to produce spike proteins to trigger an immune response. He argues the scientific community does not have a clear understanding of where the mRNA product stays in the body, for how long, and whether other proteins are created in the process. 'Science isn't propaganda,' he wrote. 'It's humility. And when public health officials stopped communicating with humility, we lost much of the public, an absolute necessity for any vaccine platform.'
